ÇмúÇà»ç ¾È³»
- ÀÏ ½Ã : 2012³â 4¿ù 22ÀÏ(ÀÏ)
- Àå ¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ ¼Ò°­´ç ¹× 1¼¼¹Ì³ª½Ç

»çÀüµî·Ï
- »çÀüµî·Ï ¸¶°¨ÀÏ : 2012³â 4¿ù 19ÀÏ(¸ñ)
- ÀԱݰèÁ : ±¹¹ÎÀºÇà 462237-01-002296 (¿¹±ÝÁÖ: ´ëÇѰñ´Ù°øÁõÇÐȸ)
* »çÀüµî·Ï½Ã ¼º¸í, ¼Ò¼Ó, Àü°øºÐ¾ß, ÀÇ»ç¸éÇã¹øÈ£, ÁÖ¼Ò, ÀüÈ­¹øÈ£, ÆÑ½º¹øÈ£, ¼Û±ÝÀÏÀ» ±âÀçÇØ Áֽñ⠹ٶø´Ï´Ù.
Expert Meeting µî·Ïºñ
±¸ºÐ »çÀüµî·Ï
Á¤È¸¿ø/ºñȸ¿ø 5¸¸¿ø

Ãá°è¿¬¼ö°­Á µî·Ïºñ (Æò»ýȸ¿øÀº µî·Ïºñ(¿¬¼ö°­Á ¸¸) ¹«·á ÀÔ´Ï´Ù.)
±¸ ºÐ Á¤È¸¿ø ºñȸ¿ø
»çÀüµî·Ï ´çÀϵî·Ï »çÀüµî·Ï ´çÀϵî·Ï
ÀüÀÓÀÇ, °øº¸ÀÇ,
±ºÀǰü,¼®»ç±ÞÀÌÇÏ ¿¬±¸¿ø

3¸¸¿ø

4¸¸¿ø 4¸¸¿ø 5¸¸¿ø
°³¿øÀÇ, ºÀÁ÷ÀÇ, ¹Ú»ç±Þ ¿¬±¸¿ø
4¸¸¿ø 5¸¸¿ø 5¸¸¿ø 6¸¸¿ø
Àü°øÀÇ 1¸¸¿ø 2¸¸¿ø

ÆòÁ¡ : ´ëÇÑÀÇ»çÇùȸ 6Á¡, ´ëÇѹæ»ç¼±Çùȸ 2Á¡

ÇÁ·Î±×·¥

¢Â 2012³â Ãá°è¿¬¼ö°­ÁÂ
°³È¸»ç

Session I : °ñ´Ù°øÁõÀÇ ±âÃÊ
ÁÂÀå : ±èÁ¤±¸ (¼­¿ïÀÇ´ë »êºÎÀΰú), ¿ø¿¹¿¬ (¾ÆÁÖÀÇ´ë Á¤Çü¿Ü°ú)
09:00-09:20 °ñ´Ù°øÁõ ¹× °ñÀýÀÇ ¿ªÇÐ À̵¿¿Á (±¹¸³¾Ï¼¾ÅÍ »êºÎÀΰú)
09:20-09:40 Sex-steroid and bone ±è¼ºÈÆ (¿ï»êÀÇ´ë »êºÎÀΰú)
09:40-10:00 °ñ´Ù°øÁõ Áø´ÜÀÇ ±âÃÊ ¾ç½Â¿À
(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø ¿µ»óÀÇÇаú)
10:00-10:30 Transforming Growth Factor Beta Enhances Osteoclast Support of
Bone Formation by Stimulating Wnt10b Production
Kuniaki Ota
(Mayo Clinic, USA)

10:30-10:50 Coffee Break

Session II : º¸Çè±ÔÁ¤ ¹× °³¿ø°¡¿¡¼­ÀÇ °ñ´Ù°øÁõ Áø·á
ÁÂÀå : ÃÖÈÆ (ÀÎÁ¦ÀÇ´ë »êºÎÀΰú)
10:50-11:10 °³Á¤µÈ °ñ´Ù°øÁõ °ü·Ã º¸Çè±ÔÁ¤ ±è¹üÅà (¾ÆÁÖÀÇ´ë °¡Á¤ÀÇÇаú)
11:10-11:30 °³¿ø°¡¿¡¼­ÀÇ °ñ´Ù°øÁõ Áø·á, ºí·ç¿À¼ÇÀΰ¡? ¿ø¿µÁØ (¿¬¼¼¿ø³»°úÀÇ¿ø)

Special Lecture
ÁÂÀå : ¿ø¿¹¿¬ (¾ÆÁÖÀÇ´ë Á¤Çü¿Ü°ú )
11:30-12:10 Strategic Management of Osteoporosis with Raloxifene Bruce Ettinger
(Kaiser Permanente, USA)
12:10-12:30 Discussion

Session III : °ñ´Ù°øÁõÀÇ ¾à¹°Ä¡·á
ÁÂÀå : ÃÖ¿õȯ (ÇѾçÀÇ´ë ³»ºÐºñ³»°ú), °­º´¹® (¿ï»êÀÇ´ë »êºÎÀΰú)
13:50-14:20 °ñ´Ù°øÁõ Ä¡·á¿¡¼­ ComplianceÀÇ Á߿伺°ú
»õ·Î¿î Bisphosphonate Á¦Çü
¹Ú¿¹¼ö (ÇѾçÀÇ´ë Á¤Çü¿Ü°ú)
14:20-14:40 Ä®½·°ú ºñŸ¹Î D ¼·Ãë¿¡ °üÇÑ ÃÖ±Ù ³í¶õ ÃÖÇѼ® (µ¿±¹ÀÇ´ë ³»ºÐºñ³»°ú)
14:40-15:00 Bisphosphonate ÀÇ ½ÇÁ¦ÀûÀÎ »ç¿ë Áõ·Ê ±è¼¼È­ (°üµ¿ÀÇ´ë ³»ºÐºñ³»°ú)
15:00-15:20 »õ·ÎÀÌ ÀÓ»ó¿¡¼­ »ç¿ëµÉ New SermÀÇ Àå´ÜÁ¡ ÀÌÁö¿µ (°Ç±¹ÀÇ´ë »êºÎÀΰú)

15:20-15:40 Coffee Break

Session IV : ´ëÇ¥ÀûÀÎ °ñ´Ù°øÁõ¼º °ñÀýÀÇ ÀÓ»óÀû °íÂû
ÁÂÀå : ÀÌÁ߸í (±¹¸³Áß¾ÓÀÇ·á¿ø Á¤Çü¿Ü°ú), ½Åº´ÁØ (¼øÃµÇâÀÇ´ë Á¤Çü¿Ü°ú)
15:40-16:00 Asymptomatic vertebral fracture ÀÇ ÀÇ¹Ì¿Í Áø´Ü ÀÌÀçÇù (¼­¿ïÀÇ´ë Á¤Çü¿Ü°ú)
16:00-16:20 ºñÁ¤Çü¿Ü°ú Àǻ簡 ±Ã±ÝÇØ Çϴ ôÃß°ñÀý Ä¡·á ¾çÁØ¿µ (Ãæ³²ÀÇ´ë Á¤Çü¿Ü°ú)
16:20-16:40 Hip fractureÀÇ ÀÇ¹Ì¿Í Áø´Ü ¹®°æÈ£ (ÀÎÇÏÀÇ´ë Á¤Çü¿Ü°ú)
16:40-17:00 Hip fractureÀÇ ¿¹¹æ°ú Ä¡·á Á¶À±Á¦ (°æÈñÀÇ´ë Á¤Çü¿Ü°ú)


¢Â Á¦ 9ȸ Expert Meeting
°³È¸»ç

Session I : Animal models of osteoporosis
ÁÂÀå : Á¤À±¼® (¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú)
09:00-09:30 Ovariectomy model, LPS or vitamin D injection model, healing model, transgenic and knock-out model Á¤Àçȯ
(°æºÏÀÇ´ë »ýÈ­Çм¼Æ÷»ý¹°Çаú)
09:30-10:00 Steroid model, aging model, immobilization model Á¤À±¼® (¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú)

10:00-10:20 Coffee Break

Session II : Arthritis and osteoporosis
ÁÂÀå : ¹Ú¿¹¼ö (ÇѾçÀÇ´ë Á¤Çü¿Ü°ú)
10:20-10:30 Overview of arthritis and osteoporosis ±èÅÂȯ (ÇѾçÀÇ´ë ·ù¸¶Æ¼½º³»°ú)
10:30-10:50 Lessons from arthritis: clinical aspects ½É½Âö (À»ÁöÀÇ´ë ·ù¸¶Æ¼½º³»°ú)
10:50-11:10 Lessons from arthritis: basic aspects Á¶¹Ì¶ó
(°¡Å縯ÀÇ´ë ·ù¸¶Æ¼½º¿¬±¸¼¾ÅÍ)

Session III : Bone (and joint) histomorphometry
ÁÂÀå : ÃÖÁ¦¿ë (°æºÏÀÇ´ë »ýÈ­Çм¼Æ÷»ý¹°Çаú)
11:10-11:20 Introduction ÃÖÁ¦¿ë
(°æºÏÀÇ´ë »ýÈ­Çм¼Æ÷»ý¹°Çаú)
11:20-11:40 °­ÀÇ ±èÁ¤Àº (°æºÏÀÇ´ë ºÐÀÚÀÇÇб³½Ç)
11:40-12:10 ½Ç½À ÀÓ°æÀº
(°æºÏÀÇ´ë »ýÈ­Çм¼Æ÷»ý¹°Çаú)

Special Lecture & Discussion
11:10-12:40 Identification and characterization of novel osteoclastogenic regulators ¿¬¹Î¿µ (Univ. Tokyo, Japan)

12:40-13:40 Luncheon

Session IV : Image-based microbiomechanics of bone
ÁÂÀå : ¿ø¿¹¿¬ (¾ÆÁÖÀÇ´ë Á¤Çü¿Ü°ú)
13:40-13:50 Introduction of image based analysis in osteoporosis ¿ø¿¹¿¬ (¾ÆÁÖÀÇ´ë Á¤Çü¿Ü°ú)
13:50-14:10 Animal DXA PIXI-mus °­ÀÇ ¹× ½Ç½À Á¤À±¼®,À̺´ÁÖ
(¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú)
14:10-14:50 Micro-CT image and analysis °­ÀÇ ¹× ½Ç½À ¹é¸íÇö
(¾ÆÁÖÀÇ´ë ÀÇ·á±â±âÀÓ»ó½ÃÇè¼¾ÅÍ)

14:50-15:10 Coffee Break

Session V : Cell culture studies including primary or established cell lines
ÁÂÀå : °íÁ¤Å (Àü³²´ë Ä¡Àü¿ø)
15:10-15:40 Experimental methods in osteoblasts: Isolation and culture of
osteoblast cells, ALP acitivity, ALP and Alizarin Red staining etc.
°íÁ¤Å (Àü³²´ë Ä¡Àü¿ø)
15:40-16:10 Experimental methods in osteoclasts: Bone marrow preparation from
long bone, Osteoclast culture: primary cells from mice & human,
TRAP staining, Pit formation assay, Fusion assay, Survival assay,
Retrovirus infection
±è³«¼º (Àü³²ÀÇ´ë ¾à¸®ÇÐ)

Session VI : Genes and genetic studies in animals and human
ÁÂÀå : ±èÁ¤±¸ (¼­¿ïÀÇ´ë »êºÎÀΰú)
16:10-16:30 Genetic study in osteoporosis - approach and method
±èÈÆ (ÀÎõÀÇ·á¿ø »êºÎÀΰú)
16:30-16:50 DNA extraction, Hypothesis, NIH searching, PCR primer orde,
agarose gel, DNA sequencing, Taqman assay, real-time PCR
À̵¿¿Á (±¹¸³¾Ï¼¾ÅÍ »êºÎÀΰú)
16:50-17:00 Interpretation of results including haplotyping, Hardy-Weinberg
equilibrium, Bonferroni
À̵¿À± (»ï¼º¼­¿ïº´¿ø »êºÎÀΰú)